There are currently 7 active clinical trials seeking participants for Coronavirus Infection research studies. The states with the highest number of trials for Autism participants are California, Texas, New York and São Paulo.
Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2)
Recruiting
Randomized, double-blind prospective trial to test the efficacy of therapeutic, antiseptic mouth rinses to inactivate severe acute respiratory syndrome coronavirus (SARS-CoV-2) in saliva of COVID-19 positive patients aged 18-65 years old. All mouthrinses are commercially available and will be used according to on-label instructions. Patients will be randomized to a mouthrinse and will be asked to give a saliva sample immediately before and after a one minute mouthwash. Saliva samples will be col... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
09/22/2023
Locations: General and Oral Health Center, Chapel Hill, North Carolina
Conditions: COVID-19, Coronavirus Infection, SARS CoV 2 Infection
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Recruiting
The novel coronavirus (SARS-CoV-2) has spread all around the world and testing has posed a challenge globally. Health care providers are highly exposed and are an important group to test. On top of these concerns, health care workers are also stressed by the needs on responders in the COVID-19 crisis. The investigators will look at different ways to measure how common COVID-19 is among health care workers, how common is the presence of antibodies by serological tests (also known as serostatus).... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/15/2023
Locations: NewYork-Presbyterian Hosptial/Columbia University Irving Medical Center, New York, New York
Conditions: Covid-19, Coronavirus Infection, Coronavirus
NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection
Recruiting
This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS CoV-2 infection, in which participants will receive NA-831 or Atazanavir with or without Dexamethasone.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
01/31/2022
Locations: Coronavirus Research Institute- Testing Site, Los Angeles, California +30 locations
Conditions: Coronavirus Infection, Severe Acute Respiratory Infection, Severe Acute Respiratory Syndrome Coronavirus 2
A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
Recruiting
This is a Phase II interventional study testing whether treatment with hydroxychloroquine, Vitamin C, Vitamin D, and Zinc can prevent symptoms of COVID-19
Gender:
All
Ages:
18 years and above
Trial Updated:
10/19/2021
Locations: ProgenaBiome, Ventura, California
Conditions: COVID-19, Coronavirus Infection, Sars-CoV2, Corona Virus Infection, COVID, Coronavirus, Coronavirus-19, Coronavirus 19
Post COVID-19 Biorepository
Recruiting
Establish a biorepository, clinical data registry, and radiographic image database from individuals who were COVID positive at one time and are being seen for outpatient follow-up or a separate study visit.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/28/2021
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Coronavirus Infection
Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19
Recruiting
The purpose of the study is to design and execute a prospective, longitudinal, descriptive cohort study in a pragmatic clinical practice for adults with symptoms that may be related to COVID-19.
Gender:
All
Ages:
Between 18 years and 114 years
Trial Updated:
09/27/2021
Locations: Seattle Intstitute of East Asian Medicine, Seattle, Washington
Conditions: Coronavirus Infection
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
Recruiting
This is a prospective study, involving contacting potential plasma donors and the use of their plasma to help fight off infections of those suffering from COVID19 in accordance to collection guidelines for plasma and FDA IND requirement. This study will include up to 240 participants potentially receiving convalescent plasma and up to 1000 potential donors. There are 3 basic arms to the study: mild, moderate and severe/critical severity. All 3 severity groups are eligible for enrollment, but mi... Read More
Gender:
All
Ages:
31 days and above
Trial Updated:
05/01/2020
Locations: WVU Medicine, Morgantown, West Virginia
Conditions: COVID19, Coronavirus Infection, Coronavirus, Virus Diseases, RNA Virus Infections